PTAB Remains Unwilling to Deny Inter Partes Review Based on a Contractual Forum-Selection Clause

Nov 16, 2020

Reading Time : 2 min

The contract at issue was a nondisclosure agreement (NDA) that the parties had entered into “for the purpose of sharing confidential information to further [their] business relationship,” including information related to the patent owner’s proprietary technology. The NDA contained a forum selection clause under which the parties “agreed to resolve any disputes regarding the NDA and ‘the transactions contemplated hereby’ . . . in ‘a court of competent jurisdiction, federal or state, located within the Borough of Manhattan, City of New York.’” After the parties’ dealings eventually fell apart, the patent owner sued the petitioner for infringement and breach of contract in New York federal court. The petitioner countered by seeking an IPR on one of the allegedly infringed patents.

Invoking the NDA’s forum selection clause, the patent owner argued that contractual estoppel barred the petition, and it asked the board to deny institution under § 314(a), which allows discretionary denials where the information presented shows that the petitioner lacks a “reasonable likelihood” of success. The patent owner asserted that, although the board previously had rejected similar arguments, it had never “considered whether it may take into account such forum selection clauses under its plenary, discretionary authority . . . to decide when to institute IPR proceedings,” and that “the circumstances in this case warrant [it] doing so.”

In rejecting the patent owner’s contractual estoppel defense, the board first highlighted its prior decisions holding “that contractual estoppel is not a defense to inter partes review.” The board noted that some of those decisions even involved “contractual bar argument[s]” based on forum selection clauses specifically. As the board explained, it is not bound by such clauses and does not have “independent jurisdiction to resolve any contractual dispute” regarding them.

The board next reasoned that the relevant “equitable considerations” under § 314(a)—which include “factors related to . . . efficiency, fairness, and the merits”—did not justify a discretionary denial. The board emphasized that it could not, and would not, blindly accept that the district court in the parallel proceeding likely “would enjoin [the] Petitioner from participating in the IPR,” as the patent owner argued. Rather, the board would have to assess the merits of the patent owner’s estoppel defense, including by interpreting the forum selection clause “and the scope of the parties’ NDA under New York and 2nd Circuit law, as well as [the] Petitioner’s contentions to the contrary.” The board explained that making such determinations would be inconsistent with its prior decisions “expressly declining to consider forum selection clauses,” and that the equitable factors simply did not support denying the petition.

Practice Tip: The board’s ruling is a stark reminder that a contractual forum-selection clause, by itself, likely will not shield a patent owner from inter partes review. Patent owners should keep this in mind, not only when formulating their arguments for opposing an IPR petition, but also when drafting NDAs or other agreements with potential infringers. For instance, a patent owner should additionally consider negotiating for an express covenant not to challenge its patents before the Patent Office. The patent owner may then seek enforcement of such a covenant via injunctive relief in the agreed-upon forum.

 

Case: Samsung Elecs. Am, Inc. v. Kannuu Pty, Ltd., IPR2020-00738, Paper 22 (PTAB Sept. 23, 2020)

Share This Insight

Previous Entries

IP Newsflash

December 18, 2025

The Federal Circuit recently vacated a $20 million jury verdict in favor of a patentee and remanded with instructions to dismiss the case for lack of subject matter jurisdiction, finding that the patentee did not own the asserted patents at the time it filed suit and therefore lacked standing.

...

Read More

IP Newsflash

December 17, 2025

The Federal Circuit recently affirmed a Patent Trial and Appeal Board decision finding claims that had been subject to an ex parte reexamination unpatentable. As a threshold issue, the court held that IPR estoppel under 35 USC § 315(e)(1) does not apply to ongoing ex parte reexaminations. Accordingly, the Patent Office did not err in continuing the reexamination after issuing final written decisions in co-pending IPRs.

...

Read More

IP Newsflash

December 15, 2025

The District of Delaware recently denied a defendant’s motion to dismiss plaintiff’s demand for enhanced damages based on willful infringement pursuant to 35 U.S.C. § 284, explaining that neither a demand for damages under § 284 nor an accusation of willful infringement amount to a claim for relief that can be subject to dismissal under Rule 12(b)(6).

...

Read More

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.